SCHEMBL27802575

SCHEMBL27802575

NC(=O)c1ccccc1C1CCN1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 11/20 0.51
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42
HSD17B10 Q99714 1/20 0.42
SIRT2 Q8IXJ6 2/20 0.42
ADRA1A P35348 1/20 0.40
METAP2 P50579 1/20 0.40
BCAT2 O15382 1/20 0.39
HSD11B1 P28845 1/20 0.38
TP53 P04637 1/20 0.38
PARP2 Q9UGN5 2/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27806404 1.00 PARP1 (0.51) PARP1KDM4EALDH1A1MAPTHPGD
SCHEMBL28944768 0.88 PARP1 (0.54) PARP1PARP2
SCHEMBL27823213 0.88 PARP1 (0.54) PARP1PARP2
SCHEMBL27814421 0.87 PARP1 (0.55) PARP1SIRT2TP53PARP2
Hydrochloric Acid SCHEMBL27637867 0.85 PARP1 (0.54) PARP1SIRT2TP53PARP2
SCHEMBL31424094 0.84 ALDH1A1 (0.46) PARP1KDM4EALDH1A1MAPTHPGD
SCHEMBL38652322 0.83 PARP1 (0.41) PARP1KDM4EALDH1A1MAPTHPGD
SCHEMBL3254494 0.80 PARP1 (0.55) PARP1KDM4EALDH1A1MAPTHPGD
SCHEMBL27851684 0.78 PARP1 (0.41) PARP1KDM4EALDH1A1MAPTHPGD
SCHEMBL28227059 0.78 PARP1 (0.37) PARP1KDM4EALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102471351-A 2-carboxamide cyclosemicarbazides as PI3K inhibitors NOVARTIS AG 2012-05-23 CN disclosed
CN-101952282-A Thiazole derivatives as PI 3 kinase inhibitors NOVARTIS AG 2011-01-19 CN disclosed
CN-101939319-A Bis-thiazole derivatives, process for their preparation and their use as medicaments NOVARTIS AG 2011-01-05 CN disclosed